Sub menu

 

 

Magnesium citrate - dibasic tetrahydrate

Compositional guideline for 'Magnesium citrate - dibasic tetrahydrate' permitted for use in listed medicines

Last updated

Name of the ingredient

Magnesium citrate - dibasic tetrahydrate (AAN)

Definition of the ingredient

Magnesium citrate - dibasic tetrahydrate has the molecular formula C6H6MgO7, xH2O, where x = 4.

Molecular mass: 286 (214.5 for anhydrous substance)

Table 1. Ingredient specific requirements
TestMethod referenceAcceptance criteria
Description
Characteristics
Identification
Assay
AppearanceVisualWhite or almost white, fine hygroscopic powder
SolubilityBP (General notice)Soluble in water, dilute hydrochloric acid and dilute nitric acid; practically insoluble in ethanol (96%)
Appearance of solutionPh Eur method 2.2.2, Method II (see Note 1)The solution is not more intensely coloured than the reference solution BY6
pH of solutionPh Eur method 2.2.3 (see Note 2)3.5-4.5
Loss on drying (1.000 g dried in an oven for 5 h at 180±10°CPh Eur method 2.2.3222.2-28.2%
CitratePh Eur method 2.3.1Complies
MagnesiumPh Eur method 2.3.1Complies
MagnesiumPh Eur method 2.5.1110.7-12.0% (dried basis)

Notes

  1. The test solution is prepared in the following manner: Dissolve 0.75g of the substance in 5 mL dilute hydrochloric acid R using heat. Cool and dilute to 30 mL with distilled water.
  2. A 2.5% solution of the substance in carbon dioxide-free water.
Table 2. Incidental constituents
TestMethod referenceAcceptance criteria
Incidental metals and non-metals
Other organic or inorganic impurities or toxins
Microbiology
Heavy metalsPh Eur method 2.4.8No more than 10 ppm
IronPh Eur method 2.4.9 (see Note 3)No more than 100 ppm
OxalatesAs per Ph Eur monograph 2339No more than 280 ppm
Sulfuric acid reaction (readily carbonisable substances)Ph Eur method 2.2.2 (Method II) (see Note 4)The solution is not more intensely coloured than the reference solution Y2
SulfatesPh Eur method 2.4.13 (see Note 5)No more than 0.2%
CalciumPh Eur method 2.4.3 (see Note 6)No more than 0.2%
While substance manufacturers are encouraged to include limits for objectionable microorganisms, it is the product into which those substances are formulated that is subject to a legally binding set of criteria. The Therapeutic Goods Order No. 77 'Microbiological Standards for Medicines' mandates that any finished product which contains the ingredient, alone or in combination with other ingredients, must comply with the microbial acceptance criteria set by Clause 9 of the Order.

Notes

  1. The solution used is prepared by diluting 4 mL of the test solution (see Note 1) to 10 mL with distilled water R.
  2. Mix 0.2 g substance with 10 mL sulphuric acid R and heat in water bath at 90±1°C for 60 min. Cool rapidly.
  3. The solution used is prepared by diluting 3 mL of the test solution (see Note 1) to 15 mL with distilled water R.
  4. The solution used is prepared by taking 2 mL of the test solution (see Note 1) and 8 mL of distilled water R, and adding 0.2 mL of dilute ammonia solution R and adjusting the pH to 3.6 (according to Ph Eur method 2.2.3). Make up to a volume of 15 mL.

Key to abbreviations

BP = British Pharmacopoeia

Ph Eur = European Pharmacopoeia

Print version

Product types